Your Account
close button

Use our patient tools for secure, convenient, 24/7 access. Learn more

OR

This facility is a member of


Connect with us:

News

New high-tech microscope aids doctors, patients

 

Glendale Heights - Adventist GlenOaks Hospital has purchased a revolutionary new microscope shown to enhance the safety and results of patients undergoing cataract surgery.

The OPMI Lumera operating microscope, manufactured by Dublin, Calif.-based Carl Zeiss Meditec, utilizes cutting-edge technology to help surgeons better visualize the eye’s delicate inner structure. Dr. Lisa Wohl, an ophthalmologist who is president of the medical staff at Adventist GlenOaks Hospital, said using the new microscope is like upgrading from an analog television set to the sharpest high-definition TV on the market.

The instrument gives surgeons a view of the inner eye like they’ve never had before, Wohl said. Even the most mature cataracts illuminate brightly under the light of this microscope. The result for patients is a safer, more comfortable surgical experience.

“The eye is a complex organ,” Wohl said. “By using this innovative technology, Adventist GlenOaks Hospital can offer the highest quality care to patients who need cataract surgery.”

Adventist GlenOaks Hospital is one of the first hospitals in the greater Chicago region to acquire the microscope, which cost more than $100,000 and was partially underwritten by the GlenOaks Hospital Foundation.

During surgery, the microscope filters out potentially harmful ultraviolet rays and shines less light on a patient’s eye, which aids recovery. In addition, it features video recording capabilities for hospital teaching purposes.

The instrument is particularly useful for cataract procedures. While its popularity is gaining strong ground here in the United States, industry leaders say the microscope already has a wide following in Europe and Japan.

“Adventist GlenOaks Hospital has always maintained a cutting-edge approach to cataract surgery,” said Brinsley Lewis, the hospital’s chief executive officer. “This is another example of how that approach benefits our patients in the community.”